The distribution of DNA synthesising cells in the crypts ofthe epithelium in human small and large bowel after injection of bromodeoxyuridine into patients has been studied in relation to the position of the cells in the crypt using immunohistochemistry. Different sites of normal epithelium have been studied. The ileum has a shorter crypt and a very significantly smaller total cell population size. However, it has similar peak labelling index (LI) values to the colon, while the rectum has a lower peak LI value. The mean position of the label occurs at the 17th cell position in the ileum and at about the 22nd position in both the colon and rectum. The overall mean LI is significantly higher in the ileum at 17*8%, intermediate in the colon at 10*3%, and lowest in the rectum at 8-5%. There is thus an inverse relation between the likelihood of developing a tumour and the rate of cell proliferation as measured by the LI. Assuming a value of 8-6 hours for the duration of S, the data suggest that the cell cycle time in the mid crypt region is about 30 hours for the ileum and colon and about 37 hours for the rectum. Samples taken adjacent (within 1 cm) to a tumour show a general dampening of proliferative activity at all cell positions compared with samples taken more than 5 cm from a tumour. This is illustrated by the average LI, which is about 5 4% in the colon adjacent to a tumour compared with 10% distant; comparable values for the rectum are 4*6% and 8*5%. Samples taken from two patients with polyposis coli show distributions with a significant difference in skewness compared with normal colon and a general shifting of the distribution to the right, that is to higher cell positions. There is a significant increase in the mean cell position and the position of the peak LI in the polyposis coli samples.
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Cancer of the colon is the second most common cancer in western populations. Kurihata and Aoki,' from a study of mortality statistics, have predicted an increasing trend in colon cancer in Japan, Germany, and the USA up to the year 2000. Patients diagnosed with a primary colonic cancer have an increased risk of subsequently developing additional primary tumours in this tissue, especially in the presence of adenomatous polyps.2" There have been reports of abnormal patterns of cell proliferation in the entire colonic mucosa of patients with colonic adenoma or cancer.' Thus investigations into the process of carcinogenesis in this tissue are indicated.
There is evidence that human mucosal proliferation may be modified in benign and malignant disease states. Increased cell proliferative rates are reported in the mucosa of patients with ulcerative colitis.78 Familial polyposis coli is a premalignant condition. Atypical proliferation zones are reported in familial polyposis coli polyps and mucosa.9"0 The characteristics of mucosal kinetics may also change with proximity to a tumour.41' 12 Some authors have reported a change in proliferation with anatomical site along the colon,'34 although we have not found this to be the case in a large series of human material."
Studies on the rate of proliferation in human gastrointestinal epithelium may provide some insight into the changes that are involved in adenoma formation and carcinogenesis in this tissue. They may also provide some clues as to the relation between proliferation and the risk of adenocarcinoma development. There have been many studies over the years that have attempted to measure proliferative indices in human intestine. 15 However, many of these have involved small biopsy samples, short term incubations in vitro using tritiated thymidine, and often relatively few patients. We have recently accumulated many samples of gastrointestinal material from patients undergoing gastrointestinal resection as a consequence of localised gastrointestinal tumours. The patients received bromodeoxyuridine (BrdUrd) shortly before admission to the theatre and the removal of normal and abnormal gastrointestinal tissue. Hence, we are in a position to analyse the in vivo proliferative index in a variety of situations. We have recently reported our technical approach in some detail"s and illustrated the sensitivity and power of the technique in detecting differences in proliferation in the normal human colon and rectum.
The presence of BrdUrd incorporated into the DNA of S phase (DNA synthesising) cells is detected here using an appropriate monoclonal antibody and immunohistochemical approaches. We have developed a computer facilitated scoring system, whereby data for each cell position along the sides of the crypts (the crypt column) are recorded sequentially into an appropriately programmed BBC microcomputer. This permits an analysis to be made of the entire pattern of cell proliferation throughout the crypts. Frequency distributions are obtained for the fraction of S phase cells at each cell position. Here, we wish to present further data from this group of patients extending, in the first instance, our studies in the colon and rectum to the ileum, then analysing the proliferative activity adjacent to and distant from tumours in the colon and in the rectum (adjacent to the tumour is a distance of less than 1 cm, distant from the tumour is a distance greater than 5 cm), and finally to present some data from two patients (who provided five independent samples) with polyposis coli. Slides were prepared using every fourth section placed on gelatinised microscope slides. These were dewaxed, air dried, and exposed to 1% hydrogen peroxide in methanol for 30 minutes to block endogenous peroxidase activity. The tissue was then hydrolysed in 1 normal HCI at 600 C for 8 minutes, neutralised, and washed before being covered with normal rabbit serum diluted 1 in 20. The primary antibody (rat anti-BrdUrd, BU1/75 1 CR1 from Sera Labs, Crawley, Sussex) was then added 1 in 5 for 1 hour at 200 C. After washing, the secondary antibody (rabbit anti-rat peroxidase, Dako, High Wycombe, Bucks) 1 in 100 was added for 1 hour at 200 C. After washing, the slides were treated with diaminobenzidine for 15 minutes in the dark, after which the slides were weakly stained with haematoxylin. SCORING 
TECHNIQUES
Good longitudinal sections of crypts were selected for scoring using a x40 oil objective. The criterion used for selection was that the crypts had to possess a lumen and a crypt base that was at a maximum depth in comparison with all other crypts. The mid point at the crypt base was identified and the crypt was divided into equal longitudinal halves, the lowermost cell nucleus in each half was designated cell position 1, as a reference point for the computer programme which recorded and analysed the data. The characteristics of each consecutive cell moving up the side of the crypt from cell position 1 was recorded directly into a microcomputer. The information that was recorded was whether the cell was labelled or unlabelled, mitotic or a labelled mitotic cell. The scoring continued up to the mid point on the intercrypt proximal table of cells if a neighbouring crypt was present, or up to the ninth cell position past the neck of the crypt if no neighbouring crypt was present, or to the crypt villus junction if a villus was present. Fifty half crypt sections were scored from each sample wherever possible using a x40 oil objective. The computer programme which has been developed could then produce frequency histograms for each category of cells and various statistical parameters connected with the data such as the overall mean labelling index (LI), the median, the 95th centile, the peak LI (defined as the Distant (7) Colon (77) \,4440. Distant 
Results
The variations in proliferative activity with each position in the crypts of the ileum, colon, and rectum are shown in Figure 1 and Figure 1 ) is significantly lower in the ileum (17-0, 21.6, and 22.3 cell positions respectively for ileum, colon, and rectum). The median values are 16-7, 20-0, and 20-8 respectively. These differences are also reflected when the 95th centile is considered (29.9, 43.1, and 44.3 cell positions respectively). This is a measure of how far up the crypt the label spreads. The peak LI is similar in the ileum and colon but is significantly lower in the rectum (29.0, 28.4, and 23-5% respectively). However, there is no difference in the position ofthe peak LI, which occurs at about the 15th or 16th cell position in each case. The mean mitotic indices (MI) differ significantly in a fashion similar to the mean LI. In summary, the data on the changes with site show that the ileum has a shorter crypt but has similar peak LI values to the colon, while the rectum has a similar length crypt to the colon but lower peak LI values.
Since the ileal crypts are significantly shorter, an alternative way of analysing the data is to express these parameters relative to the crypt length. If this is done, the mean values occur at 52% of the crypt length for the ileum and at 26-28% for the colon and rectum. The 95th centile occurs at 92% of the crypt length in the ileum but 52-56% for the colon and rectum, while the peak LI occurs at 46% of the crypt length in the ileum and 18 and 19% for the colon and rectum respectively. There is thus proportionately (in terms of cell position) more proliferation near the crypt base in the colon and rectum.
The ileum has 32 6 cells in the vertical column (longitudinal sections) and 24-2 (4. Figure 2 for the colon, Figure 3 for the rectum, and in Table II The mean LI for both colonic and rectal sites adjacent to tumours in this study was 5 0 (1I 8)%, which is comparable with a LI of 4-9 (0 2)% found in human subjects with no colonic disease.4 However, sites distant from tumours have in comparison a raised mean LI of 9-4 (4-4)%. This may provide some confirmation of abnormal proliferative activity in the entire large bowel in the presence of colorectal carcinoma.
Two patients provided five samples of polyposis coli. The five samples were taken from different positions in the colon. When all five samples were pooled the data are shown in Figure  4 and Table III . There is a clear and significant shift in the distribution to the right hand side. This is evident from a significant difference in cell position ofthe 5th centile, which is higher for the polyposis coli sample (indicating a lower LI and hence proliferation at the crypt base), a significant increase in the mean cell position in the polyposis coli sample, and a significant increase in the cell position of the peak LI in the polyposis coli sample. Overall there is a significant difference in skewness between the normal colon and that of polyposis coli, with polyposis samples showing a more symmetrical distribution.
Discussion
In vivo labelling of human tumours and tissues The results clearly illustrate the sensitivity of the techniques employed here in detecting subtle variations in proliferative activity in different positions of the crypt. This is perhaps well illustrated by the data for the polyposis coli, where the average LI shows no difference from normal colon. However, there is a clear and significant shift in the position ofthe peak LI and a general movement ofproliferation to higher cell positions. Deschner and Lipkin et al"819 have noted similar shifts in the position of labelled cells in patients with a hereditary predisposition to colon cancer. The results illustrate the value of the technique for detecting cell position differences in proliferation and hence probable hierarchy or lineage differences. The technique is currently being extended and applied to analysing differences between sites, pathological conditions, and cell positions for proliferation associated nuclear antigens and oncogene expression.
We acknowledge the possible criticism that virtually all material was derived from patients with colorectal cancer, and that in some way this tissue may differ from the normal human colon. However, detailed histology has not shown any unusual features of this material. This was necessarily a selective retrospective study without appropriate non-malignant clinical controls, which would have been unacceptable. The study was not part of a predetermined protocol. Nevertheless it reports a large and unique series of clinical material.
The results for the three different sites in the intestine are interesting in relation to the distribution of tumours along the gastrointestinal tract. The greatest incidence of tumours is observed in the rectum, which has the lowest average LI, the lowest peak LI, and the lowest mean or average MI and a low LI at the crypt base. The ileum and colon have very similar peak LI values, which occur at the same position in the crypt, and higher (colon) or similar (ileum) LI values at the crypt base compared with the rectum and yet the colon has a significant tumour incidence whereas the ileum rarely develops cancer. However, it should be noted that the position of the peak LI is proportionately higher up the shorter ileal crypt than it is in the colon (49% ofits length compared with 19%). Thus it is hard to relate increased cancer risk with rates of proliferation in the crypt generally or rates of proliferation in the stem cell zones near the crypt base. There is proportionately (from a cell position point of view), but not absolutely, more proliferation in the lower regions of the large bowel crypt than in the small bowel crypt.
If the duration of the S phase is known the turnover time for the tissue can be calculated from the duration of S divided by the mean fractional LI and for the mid crypt region where the growth fraction is likely to be close to unity, the cell cycle time can be estimated from the duration of S divided by the peak fractional LI. The duration of S for the colon and rectum was estimated from flow cytometric studies to be about 8 6 hours.520 Using this value the turnover times for the ileum, colon, and rectum respectively were 48-3 hours, 83 5 hours, and 101-2 hours. If we assume that the duration of S lies between 7 and 14 hours, we can state that the turnover times for these sites lie within the ranges 39-79, 68-136, and 82-165 hours respectively. Using the peak LI values and assuming that in this mid region ofthe crypt the growth fraction is close to unity, the cell cycle times can be calculated to be 29 7 hours, 30 3 hours, and 36-6 hours respectively. This suggests that the mid crypt transit cell cycle times may be similar in the colon and ileum and slightly longer in the rectum. The ratio between this calculated cell cycle time and the turnover time provides some indication for the growth fraction for the entire crypt, which is estimated to be 0-61, 036, and 20) .
None of the evidence presented here can be considered to be conclusive evidence or rebuttal of any hypothesis concerning the genesis of neoplasia from human colorectal mucosa. However, we are able to draw together some important observations. Firstly, neither the overall rate ofcell proliferation in mucosa nor the proportion ofproliferating cells, nor the proportion of crypt base (stem) proliferating cells seem to correlate with the likelihood of neoplastic change in the tissue.
Secondly, altered patterns of proliferation seem to indicate a malignant tendency in polyposis coli, and particularly in villous adenomas. Thus, altered controls to the inter-relation of proliferating cells, such as cell recognition mechanisms, may make an important contribution to the malignant phenotype. Indeed, because the rate of tumour growth is a balance between cell production and cell loss, a diminished rate of proliferation is quite possible in tumours compared with mucosa, in which cell loss and production are precisely balanced.
We conclude that the combination of quantitative techniques which we have described offers substantial advantages for the study of colorectal mucosal proliferation, both in animal models and in human diseases, where the clinical circumstances are appropriate. Our data will form the basis for further investigations into the relation between crypt cell turnover and colorectal proliferative diseases.
